Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts

Clinical Cancer Research

Volumn 4, Issue 4, 1998, Pages 1013-1019

  Sawada, Noriaki ^a   Ishikawa, Tohru ^a   Fukase, Yu ^a   Nishida, Miwa ^a   Yoshikubo, Takashi ^a   Ishitsuka, Hideo ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; CREMOPHOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXIFLURIDINE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; PACLITAXEL; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR ALPHA; UFT; VINBLASTINE; VINCRISTINE; VINDESINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; DEOXYCYTIDINE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ENZYME INDUCTION; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PACLITAXEL; TAXOIDS; THYMIDINE PHOSPHORYLASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0031944611     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kono, H., Hara, Y., Sugata, S. Karube, Y., Matsushima, Y., and Ishitsuka, H. Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumor tissues. Chem. Pharm. Bull. (Tokyo), 31: 175-178, 1983.
2. Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., and Ishitsuka, H. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur. J. Cancer, in press, 1998.
3. Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., and Akiyama, S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res., 55: 1687-1690, 1995.
4. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C., and Harris, A. L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
5. Nishida, M., Hino, A., Mori, K., Matsumoto, T., Yoshikubo, T., and Ishitsuka, H. Preparation of anti-human thymidine phosphorylase monoclonal antibody useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull., 19: 1407-1411, 1996.
6. Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F., and Aikou, T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst., 88: 1110-1117, 1996.
7. Haraguchi, M., Furukawa, T., Sumizawa, T., and Akiyama, S. Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res., 53: 5680-5682, 1993.
8. Miwa, M., Cook, A., and Ishitsuka, H. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem. Pharm. Bull. (Tokyo), 34: 4225-4232, 1986.
9. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K., and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol., 32: 333-338, 1993.
10. Eda, H., Fujimoto, K., Watanabe, S., Ishikawa, T., Ohiwa, T., Tatsuno, K., Tanaka, Y., and Ishitsuka, H. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine. Jpn. J. Cancer Res., 84: 341-347, 1993.
11. Tevaerai, H. T., Laurent, P. L., Suardet, L., Eliason, J. F., Givel, J. C., and Odartchenko, N. Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitro. Eur. J. Cancer, 28: 368-372, 1992.
12. Schwartz, E. L., Hoffman, M., O'Connor, C. J., and Walder, S. Stimulation of 5-fluorouracil metabolic activation by interferon-α2a in human colon carcinoma cells. Biochem. Biophys. Res. Commun., 182: 1232-1239, 1992.
13. Tanaka, Y., Endo, M., Ouchi, K., Mori, K., and Ishitsuka, H. Augmentation of antitumor activity of 5′-deoxy-5-fluorouridine by IL-12 through the up-regulation of pyrimidine nucleoside phosphorylase in murine tumor models. Eur. J. Cancer, 33 (Suppl. 8): S176-S177, 1997.
14. Ishitsuka H., Ishikawa, T., Fukase, Y., Sawada, N., Tanaka, Y., Ouchi, K., Yoshikubo, T., and Nishida, M. Capecitabine and the dThdPase up-regulators IFNγ or Taxol showed synergistic activity in human cancer xenografts. Proc. Am. Assoc. Cancer Res., 37: 2766, 1996.
15. Ding, A. H., Porteu, F., Sanchez, E., and Nathan C. N. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science (Washington DC), 248: 370-372, 1990.
16. Bogdan, C., and Ding, A. Taxol, a microtubule-stabilizing antineo-plastic agent, induces expression of tumor necrosis factor α and interleukin-1 in macrophages. J. Leukocyte Biol., 52: 119-121, 1992.
17. Burkhart, C. A., Berman, J. W., Swindell, C. S., and Horwitz, S. B. Relationship between the structure of Taxol and other taxanes on induction of tumor necrosis factor-α gene expression and cytotoxicity. Cancer Res., 54: 5779-5782, 1994.
18. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., and Ishitsuka, H. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res., 50: 2290-2295, 1990.
19. Arasaki, M., Ishitsuka, H., Kuruma, I., Miwa, M., Murasaki, C., Shimma, N., and Umeda, I. N-Oxycarbonyl substituted 5′-deoxy-5-fluorocytidines. European Patent Application No. 92121538.0, 1992.
20. Eda, H., Hasegawa, M., Tatsuno, K., Matsumoto, T., Watanabe, S., Uchida, T., and Ishitsuka, H. Characteristics of human colon cancer cells transfected with thymidine phosphorylase gene (in Japanese). J. Jpn. Soc. Cancer Ther., 29: 164, 1994.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.